NoHo Partners will host a Capital Markets Day on Wednesday, 22 May.
Redeye återkommer med en update efter BioArctics Q1-rapport.
Consti’s backlog for 2024 coupled with a robust balance sheet protects it from short-term market tur...
Nettoomsättningen för det första kvartalet uppgick till 10,9 MEURO (9,4), vilket motsvarade en öknin...
Redeye initiates coverage of Navigo Invest, a holding company of strategic acquirer platforms.
Redeye thinks that Lagercrantz reported a solid quarter despite a drop in organic sales.
AAC Clyde Space offers exposure to the fast-growing low Earth orbit space market.
Hög försäljningstillväxt EQL Pharma ökade de återkommande intäkterna med 46,0 procent, vilket var i ...
22% organic sales growth y-o-y Lower than expected gross margin Price increases should help gross ma...
Björn Borg (”Björn Borg” or ”the Company”) published its Q1 report for 2024 on the 16th of May, 2024...
Redeye concludes that the figures in the report exceeded our expectations.
Record start to '24, driven by Capital Markets and PI We increase adj.
Redeye provides a reseach update following the Q1 2024 report from Fragbite Group.
Redeye saw a mixed picture in the first quarter. Sales performance was better than expected, even if...
Better Collective has acquired AceOdds which is a UK focused sports media company with products incl...
Rudd delivers SEK 60m EBIT in its first full quarter (ABGSCe 68m) EBIT down by 9-7% for '24e-'26e, l...
We make minor cuts to our estimates after Ferronordic's Q1 results.
EBIT revisions of -6% to + 3% Good order execution and financial discipline Order intake and loss fr...
Redeye leaves a research update following Klaria Pharma’s recently published Q1 2024 report.
Adj. EBIT +3% y-o-y, despite a 7% sales drop y-o-y We make small estimate revisions +16% adj.
